The vaccine efficacy of recombinant duck enteritis virus expressing secreted E with or without PrM proteins of duck tembusu virus

被引:52
作者
Chen, Pucheng [1 ]
Liu, Jinxiong [1 ]
Jiang, Yongping [1 ]
Zhao, Yuhui [1 ]
Li, Qimeng [1 ]
Wu, Li [1 ]
He, Xijun [1 ]
Chen, Hualan [1 ]
机构
[1] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Peoples R China
关键词
Recombinant DEVs; Duck tembusu virus; Vector vaccine; WEST-NILE-VIRUS; COMPLETE GENOME SEQUENCE; ENVELOPE PROTEIN; NEUTRALIZING ANTIBODY; FLAVIVIRUS; ENCEPHALITIS; MICE; DNA; CHINA; IMMUNIZATION;
D O I
10.1016/j.vaccine.2014.07.082
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A newly emerged tembusu virus that causes egg-drop has been affecting ducks in China since 2010. Currently, no vaccine is available for this disease. A live attenuated duck enteritis virus (DEV; a herpesvirus) vaccine has been used routinely to control lethal DEV in ducks since the 1960s. Here, we constructed two recombinant DEVs by transfecting overlapping fosmid DNAs. One virus, rDEV-TE, expresses the truncated form of the envelope glycoprotein (TE) of duck tembusu virus (DTMUV), and the other virus, rDEV-PrM/TE, expresses both the TE and pre-membrane proteins (PrM). Animal study demonstrated that both recombinant viruses induced measurable anti-DTMUV neutralizing antibodies in ducks. After two doses of recombinant virus, rDEV-PrM/TE completely protected ducks from DTMUV challenge, whereas rDEV-TE only conferred partial protection. These results demonstrate that recombinant DEV expressing the TE and pre-membrane proteins is protective and can serve as a potential candidate vaccine to prevent DTMUV infection in ducks. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5271 / 5277
页数:7
相关论文
共 32 条
[1]  
Aberle JH, 1999, J IMMUNOL, V163, P6756
[2]   SYNTHESIS AND SECRETION OF RECOMBINANT TICK-BORNE ENCEPHALITIS-VIRUS PROTEIN-E IN SOLUBLE AND PARTICULATE FORM [J].
ALLISON, SL ;
STADLER, K ;
MANDL, CW ;
KUNZ, C ;
HEINZ, FX .
JOURNAL OF VIROLOGY, 1995, 69 (09) :5816-5820
[3]   Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal encephalitis [J].
Appaiahgari, MB ;
Saini, M ;
Rauthan, M ;
Jyoti ;
Vrati, S .
MICROBES AND INFECTION, 2006, 8 (01) :92-104
[4]   Protective efficacy of a plasmid DNA encoding Japanese encephalitis virus envelope protein fused to tissue plasminogen activator signal sequences: studies in a murine intracerebral virus challenge model [J].
Ashok, MS ;
Rangarajan, PN .
VACCINE, 2002, 20 (11-12) :1563-1570
[5]   Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein [J].
Beasley, DWC ;
Barrett, ADT .
JOURNAL OF VIROLOGY, 2002, 76 (24) :13097-13100
[6]   West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays [J].
Davis, BS ;
Chang, GJJ ;
Cropp, B ;
Roehrig, JT ;
Martin, DA ;
Mitchell, CJ ;
Bowen, R ;
Bunning, ML .
JOURNAL OF VIROLOGY, 2001, 75 (09) :4040-4047
[7]   Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis [J].
Desprès, P ;
Combredet, C ;
Frenkiel, MP ;
Lorin, C ;
Brahic, M ;
Tangy, F .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (02) :207-214
[8]   Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses [J].
Ge, Jinying ;
Deng, Guohua ;
Wen, Zhiyuan ;
Tian, Guobing ;
Wang, Yong ;
Shi, Jianzhong ;
Wang, Xijun ;
Li, Yanbing ;
Hu, Sen ;
Jiang, Yongping ;
Yang, Chinglai ;
Yu, Kangzhen ;
Bu, Zhigao ;
Chen, Hualan .
JOURNAL OF VIROLOGY, 2007, 81 (01) :150-158
[9]  
Iyer AV, 2009, VACCINE, V27, P893
[10]   An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity [J].
Khanam, Saima ;
Pilankatta, Rajendra ;
Khanna, Navin ;
Swaminathan, Sathyamangalam .
VACCINE, 2009, 27 (43) :6011-6021